Erin DiMauro

Dr. Erin DiMauro

• B.A. in Chemistry
  Wesleyan University
• Ph.D. in Organic Chemistry (2003)
  University of Pennsylvania
• Worked in the area of bifunctional catalysis
• Currently Principal Scientist at Amgen, Boston

links
https://www.linkedin.com/in/erin-dimauro-76b01915

 https://www.facebook.com/erin.dimauro.5

• 
  Amgen

  Department of Medicinal Chemistry

  Thousand Oaks, United States

Experience

Principal Scientist, Group Leader

Amgen

February 2012 – Present (4 years 3 months)Cambridge, MA

- Medicinal Chemistry team lead and group leader on a variety of projects spanning therapeutic areas (Neuroscience, Oncology, Inflammation) and target classes (Ion channels, kinases, GPCRs, PARPs, proteases, transporters).
- Extensive experience in lead generation and optimization: delivery of high quality tools for target validation and milestone leads for project advancement.
- Direct management of organizational units comprised of B.S., M.S., and Ph.D. Interns, Associates, Scientists, and Senior Scientists.
- Routine internal and external presentations. Consistent publication in leading journals.

Senior Scientist, Group Leader

Amgen

February 2006 – February 2012 (6 years 1 month)Cambridge, MA

Scientist

Amgen

September 2003 – February 2006 (2 years 6 months)Cambridge, MA

Education

University of Pennsylvania

Ph.D., Organic Chemistry

1998 – 2003

Wesleyan University

B. A., Organic Chemistry

1994 – 1998

Publications

The development of novel dual-binders as potent, selective, and orally bioavailable tankers inhibitors(Link)

J. Med. Chem. 2013, 56, 10003-10015

Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors(Link)

ACS Med. Chem. Lett. 2013, 4, 1218

Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors(Link)

J. Med. Chem. 2013, 56, 4320-4342

Projects

GlyRa3 (Neuroscience)

Nav1.7 (Neuroscience)

Tankyrase (Oncology)

Ck1g (Oncology)

BACE (Neuroscience)

CB2 (Neuroscience)

Lck (Inflammation)

 

 

////////